首页> 外国专利> SEPARATED ANTIBODY OR FRAGMENT OF ANTIBODY THAT ARE SPECIFICALLY BOUND TO FRAGMENT OF POLYPEPTIDE RG1, IMMUNOCONJUGATE THAT INCLUDES SEPARATED ANTIBODY OF FRAGMENT OF ANTIBODY, MEANS FOR SELECTIVE DESTRUCTION OF CELL, TREATMENT OF PROSTATE CANCER, DIAGNOSTICS OF PROSTATE CANCER AND ITS METASTASES IN PATIENT, APPLICATION OF ANTIBODY AND IMMUNOCONJUGATE AS THERAPEUTIC AGENT

SEPARATED ANTIBODY OR FRAGMENT OF ANTIBODY THAT ARE SPECIFICALLY BOUND TO FRAGMENT OF POLYPEPTIDE RG1, IMMUNOCONJUGATE THAT INCLUDES SEPARATED ANTIBODY OF FRAGMENT OF ANTIBODY, MEANS FOR SELECTIVE DESTRUCTION OF CELL, TREATMENT OF PROSTATE CANCER, DIAGNOSTICS OF PROSTATE CANCER AND ITS METASTASES IN PATIENT, APPLICATION OF ANTIBODY AND IMMUNOCONJUGATE AS THERAPEUTIC AGENT

机译:与多肽RG1片段特异性结合的分离的抗体或片段,包含抗体片段的分离抗体的免疫共轭,用于肿瘤的选择性消灭,癌变的治疗方法,治疗前列腺癌的手段抗体和免疫缀合物作为治疗剂

摘要

The invention relates to separated antibody or fragment of antibody that are specifically bound to fragment of polypeptide RG1. Also the invention relates to immunoconjugate that includes separated antibody or fragment of antibody that are specifically bound to fragment of polypeptide RG1. Besides, the invention relates to the method for selective destruction of cell that expresses polypeptide, to the method for prostate cancer providing injection to the patient of therapeutically effective quantity of immunoconjugate, methods of diagnostics of prostate cancer and its metastases in patient using the superexpression RG1 metering. Also the method relates to application of antibody and immunoconjugate as therapeutic agent.
机译:本发明涉及与多肽RG1的片段特异性结合的分离的抗体或抗体的片段。本发明还涉及免疫缀合物,其包括与多肽RG1的片段特异性结合的分离的抗体或抗体片段。此外,本发明涉及选择性破坏表达多肽的细胞的方法,涉及向前列腺癌患者提供治疗有效量的免疫缀合物的注射的方法,使用超表达RG1对患者进行前列腺癌及其转移的诊断方法。计量。该方法还涉及抗体和免疫缀合物作为治疗剂的应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号